Viewing Study NCT03864666


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2026-02-24 @ 8:47 AM
Study NCT ID: NCT03864666
Status: COMPLETED
Last Update Posted: 2019-05-14
First Post: 2019-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Sponsor: Genovate Biotechnology Co., Ltd.,
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intermittent Claudication View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Peripheral Artery Disease View
None Cilostazol View
None PMR View
None Extended-Release Tablet of Cilostazol View